Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1758 of 5804
-
New stent study aims to ease bile duct blockage in pancreatic cancer patients
Disease control Not yet recruitingThis study is a multicenter, randomized clinical trial designed to compare the effectiveness and safety of a modified 8-mm fully covered self-expandable metal stent (FCSEMS) with a conventional plastic stent for preoperative biliary drainage in patients with pancreatic cancer and…
Phase: NA • Sponsor: Soonchunhyang University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy may cut muscle stiffness and botox doses for stroke survivors
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy of a combined treatment approach for post-stroke upper limb spasticity using phenol neurolysis and botulinum toxin (BoNT). Spasticity is a common post-stroke complication that leads to muscle stiffness and significantly hinders functional …
Phase: PHASE4 • Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Scientists use Mini-Brains to unlock Autism's secrets
Knowledge-focused Not yet recruitingAutism Spectrum Disorder (ASD) is a neurodevelopmental disorder affecting approximately 1% of the population, characterized by difficulties with social interaction and communication. Studies have identified more than 200 genes linked to ASD, particularly those involved in chromat…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Massive new study to track long COVID for years – no treatment, just answers
Knowledge-focused Not yet recruitingLong COVID (LC) affects an estimated 5-10% of individuals with SARS-CoV-2 causing a persistent physical, cognitive, and functional impairment with potentially severe socioeconomic consequences. While RECOVER-Adult cycle 1 established the largest, most comprehensive U.S. adult LC …
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Plasma power: could a cold gas device speed up wound healing?
Disease control Not yet recruitingThis study is a prospective, multicenter, real-world observational study. It aims to evaluate whether adding plasma device therapy to standard wound care is effective and safe for treating different types of wounds, including acute wounds (such as burns and surgical incisions), c…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Bed rest for short cervix under scrutiny: could normal activity be better?
Knowledge-focused Not yet recruitingMaternal AR has long been used to prevent PTB. However, definitions of AR vary widely, ranging from complete bed rest to partial limitation of physical activity for one or more hours daily. The use of maternal AR to prevent preterm birth is largely based on observational evidenc…
Phase: NA • Sponsor: Julie Glavind • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Which reflux treatment works best? major trial to find out
Disease control Not yet recruitingThe goal of this randomized controlled trial is to compare the effectiveness of different treatments for laryngopharyngeal reflux disease (LPRD) in adult patients with confirmed symptoms and signs of the condition. The main question it aims to answer is: Which treatment (Proton …
Phase: PHASE4 • Sponsor: University of Mons • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New stent showdown: can covered stents beat bare metal for kidney artery blockages?
Disease control Not yet recruitingAtherosclerotic renal artery stenosis is the most common cause of secondary hypertension , increasing the risk of cardiovascular and kidney-related complications. Some small-scale studies have suggested that covered stents are effective and safe, but high-quality evidence from la…
Phase: NA • Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for minority patients with hard-to-treat stomach and esophageal cancers
Disease control Recruiting nowThe purpose of this study is to characterize the clinical effects of tislelizumab, including pharmacokinetics (PK), activity, and safety assessments in US racial and ethnic minority patients with human epidermal growth factor receptor 2 (HER2)-negative, programmed death-ligand 1(…
Phase: PHASE2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New osteoporosis shot aims to strengthen bones in older women
Disease control Recruiting nowThis is a multicenter, randomized, open-label, parallel-controlled Phase II study designed to evaluate the differences in safety among four different dosing regimens of SAL056.
Phase: PHASE2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New nasal spray could quickly calm acute anxiety
Symptom relief Recruiting nowThis study employs a randomized, double-blind, placebo-controlled clinical trial design to evaluate the efficacy and safety of dexmedetomidine hydrochloride nasal spray in the treatment of acute anxiety in adults. Study Protocol: Patients meeting the criteria for acute anxiety w…
Phase: PHASE2 • Sponsor: Tongji University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
AI and wearable tech aim to catch prediabetes before it starts
Knowledge-focused Not yet recruitingPrediabetes significantly increases the risk of developing diabetes, cardiovascular and cerebrovascular diseases, tumors, and dementia. Early identification and intervention have become a leading focus in current diabetes prevention and control research. Currently, prediabetes sc…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
AI-Powered PET scans could revolutionize heart device infection diagnosis
Diagnosis Not yet recruitingSingle center, open-label, phase IV clinical trial to study the application of radiomics in molecular imaging for diagnosis and follow-up of CVDIs. The study will include three populations: * Retrospective cohort (2018-2025) * Prospective cohort (2026-2027) * Control group (pros…
Phase: PHASE4 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Mapping the infant gut: a Million-Sample quest to decode Early-Life health
Knowledge-focused OngoingThis study plans to collect 106,667 fecal samples from Chinese infants and children under 6 years old, with multi-dimensional stratification based on geographic location, mode of delivery, antibiotic exposure, and developmental stage. Fecal gut microbiota will be profiled to cons…
Sponsor: DiproBio (Shanghai) Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
New hope for advanced cancer: AK150 drug trial launches
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and dose-expansion Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of AK150 in patients with advanced malignant solid tumors.
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Smaller incision, same relief? new trial tests less invasive POEM for achalasia
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]: * Does making a smaller cut in the muscle …
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New hope for rare blood cancers: first human trial of PRT12396 begins
Disease control Recruiting nowThis is a first-in-human, open-label, multi-center Phase 1 study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of PRT12396 in participants with high-risk polycythemia vera (PV) and myelofibrosis (MF), and to determine the maximum tolera…
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Menthol gloves may offer quick itch relief for eczema sufferers
Symptom relief OngoingThe goal of this clinical trial is to learn if menthol works to relieve pruritus in atopic dermatitis. The primary objectives are to evaluate the safety and clinical efficacy of menthol-containing gloves and foot-covers, specifically whether they can improve patient-reported Peak…
Phase: PHASE2 • Sponsor: Taiwan Municipal An-Nan Hospital-China Medical University • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Thyroid cancer surgery debate: to dissect or not to dissect neck nodes?
Disease control Not yet recruitingPapillary thyroid carcinoma (PTC) is the most common endocrine malignancy and is frequently associated with microscopic central neck lymph node metastases, even in the absence of preoperative clinical evidence of nodal involvement (cN0). While prophylactic central compartment nec…
Phase: NA • Sponsor: Leonardo Rossi • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Massive 10-Year study aims to unlock Parkinson's secrets
Knowledge-focused Not yet recruitingParkinson's disease (PD) is a common neurodegenerative disorder in middle-aged and elderly individuals, with a global incidence of 2.0% among adults aged 65 and over. Its pathogenesis remains unclear, and effective preventive and therapeutic approaches are lacking. PD severely im…
Sponsor: Fujian Medical University Union Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC